DB In Vitro RNA Expression Analysis Assay (Real-time PCR)

CAT#: ITS-0123-YF3343
Target Cell Organism: Human
Target Cell Name: DB
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide DB-based In Vitro RNA Expression Analysis Assay (Real-time PCR) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
DB
Target Cell Organism
Human
Target Cell Background
The DB cell line was established by Walter J. Urba and Dan L. Longo from ascites fluid from a patient with a diffuse large cell lymphoma.
Related Diseases
Large Cell Lymphoma
Research Area
Oncology
Assay Name
In Vitro RNA Expression Analysis Assay (Real-time PCR)
Assay Description
Real-time PCR is the most commonly used platform to evaluate mRNA or miRNA expression after conversion of mRNA or miRNA into cDNA. Amplification of a target gene is evaluated by quantifying th fluorescence signal generated using DNA intercalating dyes (SYBER green) or gene-specific probes. This technique can also be used to screen gene mutations, DNA modifications and confirm results obtained from northern blotting or microarray. Additionally, real-time PCR is the most suitable tool for gene expression analysis for RNA samples with low yields compared to hybridization techniques.
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry